Drawing for GENBODY INC.

USPTO serial 97149480

GENBODY INC.

Reviewed by CopyMark Law Group

Reg. 7691751Status 700Registered
Filing date
Status date
Registration date
Feb 18, 2025
Examiner
KEATING, MICHAEL P
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with GENBODY INC.?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Martin Z. Zhang

Martin Z. Zhang Morse, Barnes-Brown & Pendleton, P.C.480 Totten Pond Road, 4th FloorCityPointWaltham, MA 02451

Goods and services

ClassDescriptionStatusFirst use
005Chemical preparations for diagnosing tuberculosis; diagnostic reagents for determining immunization status for disease; radioactive pharmaceutical preparations for in vivo diagnostics for therapeutic use; diagnostic preparations for veterinary purposes; diagnostic test reagents for veterinary purposes; diagnostic test reagents for medical or veterinary purposes; medical diagnostic reagents; reagents and media for medical and veterinary diagnostic purposes; diagnostic preparations for medical and veterinary use; diagnostic preparations for medical purposes for detecting genetic predispositions; medical diagnostic test strips for analysis or testing of bodily fluids for medical purposes; diagnostic reagents and contrast media for medical purposes; diagnostic preparations for medical purposes; in vitro diagnostic preparations for medical purposes; pregnancy testing preparations; radiopharmaceutical preparations for diagnostic purposes; diagnostic biomarker reagents for medical purposes; radio-isotope markers for diagnostic use; pharmaceutical diagnostic preparations for medical purposes; in vitro gender prediction test kitACTIVE—
010Electromedical apparatus and equipment in the nature of medical and diagnostics X-ray apparatus for X-ray diagnostics and X-ray therapy; automatic apparatus for use in biological analysis to diagnose tuberculosis; electromagnetic medical diagnostic imaging apparatus for bone density diagnosis; diagnostic apparatus for analysis of body fluid for diagnosing atherosclerosis; diagnostic apparatus for analysis and testing of body fluids for veterinary purposes; medical measuring instruments for diagnosing cancer; miniaturized patient monitoring sensors for use in gene analysis and medical condition and disease diagnosis; medical diagnostic imaging apparatus; medical apparatus for use in diagnostic analysis of body fluids; ultrasonic medical diagnostic apparatus; medical apparatus and instruments for analysis of body fluids in the fields of clinical diagnosis of infectious disease caused by transmittable virus, bacteria, or parasites; medical apparatus for medical purpose use in analysis of body fluids, analytical apparatus for medical purpose use in analysis of body fluids and blood pressure measuring; apparatus for clinical diagnosis or medical purpose for analysis of body fluids for infectious disease caused by transmittable virus, bacteria, or parasites; in vitro urine analysis devices for testing and analyzing fluid for medical purposes; immunoassay apparatus for medical diagnosis to screening patient condition and disease, namely, an infectious disease caused by transmittable virus, bacteria, or parasites; blood analysis apparatus for testing and analyzing for medical purpose for diagnosing and treating for infectious disease caused by transmittable virus, bacteria, or parasites; in vitro diagnostic devices for medical purposes for testing reagents, antigens, antibodies, hormones, metabolites, and derivativesACTIVE—
035Wholesale distributorship services for veterinary preparations; retail store services for veterinary preparations; wholesale distributorship services for medical instruments for interstitial thermotherapy of biological tissue; retail store services for medical instruments for interstitial thermotherapy of biological tissue; wholesale distributorship services for medical apparatus and instruments; retail store services for medical apparatus and instruments; wholesale distributorship services for diagnostic preparations for medical or veterinary purposes; retail store services for diagnostic preparations for medical or veterinary purposes; wholesale distributorship services for diagnostic apparatus for medical purposes; retail store services for diagnostic apparatus for medical purposes; retail and wholesale services by direct solicitation by sales agents in the field of diagnostic apparatus for medical purposes; wholesale store services for diagnostic test reagents for medical purposes; retail store services for diagnostic test reagents for medical purposes; wholesale distributorship services for medicines for human purposes; retail store services for medicines for human purposes; wholesale distributorship services for pregnancy testing preparations; retail store services for pregnancy testing preparations; wholesale distributorship services for pharmaceutical preparations for diagnosis; retail store services for pharmaceutical preparations for diagnosis; retail and wholesale services by direct solicitation by sales agents in the field of pharmaceutical preparations for diagnosisACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 18, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Feb 18, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 31, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 31, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 25, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 24, 2024OTHECASE RETURNED TO EXAMINATION—
Oct 24, 2024IUCNNOTICE OF ALLOWANCE CANCELLED—
Oct 24, 2024PCBGPETITION TO DIRECTOR - CHANGE BASIS - GRANTED—
Oct 23, 2024APETASSIGNED TO PETITION STAFF—
Oct 9, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 9, 2024EX1GSOU EXTENSION 1 GRANTED—
Oct 9, 2024EXT1SOU EXTENSION 1 FILED—
Oct 9, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 7, 2024TPADTEAS PETITION TO AMEND BASIS RECEIVED—
Apr 9, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 27, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 27, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Feb 27, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 27, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 27, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 27, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 13, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 13, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 24, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 15, 2023ALIEASSIGNED TO LIE—
Apr 27, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 27, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Apr 27, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 27, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 27, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 24, 2023ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Apr 18, 2023PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Apr 3, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 29, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Mar 29, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 29, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 29, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 23, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 22, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 22, 2023ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Sep 27, 2022GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Sep 27, 2022GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 27, 2022CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 2, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 2, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 2, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 10, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 10, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 10, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 10, 2022DOCKASSIGNED TO EXAMINER—
Dec 6, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 3, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance